Organigram Global (OGI) Assets (2018 - 2026)

Organigram Global (OGI) posted quarterly Assets of $380.1 million for Q1 2026, little changed quarter-over-quarter from $380.5 million in Q4 2025.

Organigram Global (OGI) Assets (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Assets for 9 consecutive years, with $380.1 million the latest figure, recorded in Q1 2026.

In Q1 2026, Assets changed N/A year-over-year to $380.1 million; the TTM figure through Mar 2026 stood at $380.1 million (changed N/A YoY), while the FY2025 annual figure was $380.5 million, changed N/A from the prior year.
Assets held at $380.1 million in Q1 2026 per OGI's latest filing, from $380.5 million in the prior quarter.
Across five years, Assets topped out at $448.1 million in Q3 2022 and bottomed at $222.6 million in Q3 2023.
Historically, Assets has averaged $356.5 million across 5 years, with a median of $380.3 million in 2025.
Annual changes were most pronounced in 2022 — Assets grew 0.55% — and 2025, when it jumped 36.64%.
Organigram Global's Assets stood at $448.1 million in 2022, then sank by 50.32% to $222.6 million in 2023, then jumped by 34.3% to $299.0 million in 2024, then gained by 27.28% to $380.5 million in 2025, then retreated by 0.1% to $380.1 million in 2026.
Business Quant data shows OGI's Assets at $380.1 million in Q1 2026, $380.5 million in Q4 2025, and $408.5 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	43.71 Bn
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn	39.86 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	15.08 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn	98.27 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn	7.22 Bn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn	35.04 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn	5.36 Bn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn	13.56 Bn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	6.18 Bn
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn	380.14 Mn

Download Data